NEXVET BIOPHARMA PUB LTD CO - ORD SHS (NVET)

CUSIP: G6503X109

Q1 2016 13F Holders as of 31 Mar 2016

Type / Class
Equity / ORD SHS
Total 13F shares
5,735,953
Share change
-55,597
Total reported value
$18,929,000
Price per share
$3.30
Number of holders
16
Value change
-$238,050
Number of buys
5
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP G6503X109?
CUSIP G6503X109 identifies NVET - NEXVET BIOPHARMA PUB LTD CO - ORD SHS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NEXVET BIOPHARMA PUB LTD CO - ORD SHS (NVET) as of Q1 2016

As of 31 Mar 2016, NEXVET BIOPHARMA PUB LTD CO - ORD SHS (NVET) was held by 16 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,735,953 shares. The largest 10 holders included FARALLON CAPITAL MANAGEMENT LLC, Broadfin Capital, LLC, Foresite Capital Management II, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Boxer Capital, LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, NORGES BANK, PANAGORA ASSET MANAGEMENT INC, COWEN GROUP, INC., and BANK OF AMERICA CORP /DE/. This page lists 16 institutional shareholders reporting positions in this security for the Q1 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.